Open AccessEfficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
Author(s) -
Mario Salvi,
Guia Vannucchi,
Nicola Currò,
Irene Campi,
Danila Covelli,
Davide Dazzi,
Simona Simonetta,
Claudio Guastella,
Lorenzo Pignataro,
Sabrina Avig,
Paolo BeckPeccoz
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2014-3014
Subject(s) - rituximab , medicine , randomized controlled trial , oncology , lymphoma
Preliminary studies have shown that rituximab (RTX) is effective in the treatment of active Graves' orbitopathy (GO).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom